Kansanterveyslaitos KTL

Viitteet 1-1 / 1

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

Paavonen J; Jenkins D; Bosch FX; Naud P; Salmerón J; Wheeler CM; Chow S-N; Apter DL; Kitchener HC; Castellsague X; Carvalho NS de; Skinner SR; Harper DM; HedrickJA; Jaisamrarn U; Limson GAM; Dionne M; Quint W; Spiessens B; Peeters P; Struyf F; Wieting SL; Lehtinen MO; Dubin G; for the HPV PATRICIA study group
Lancet : 9580 (2007)

"Quint W" - Selaus tekijän mukaan Kansanterveyslaitos KTL